Chemfab Alkalis Balance Sheet Health
Financial Health criteria checks 4/6
Chemfab Alkalis has a total shareholder equity of ₹3.9B and total debt of ₹792.3M, which brings its debt-to-equity ratio to 20.5%. Its total assets and total liabilities are ₹5.3B and ₹1.5B respectively. Chemfab Alkalis's EBIT is ₹184.7M making its interest coverage ratio 20. It has cash and short-term investments of ₹27.9M.
Key information
20.5%
Debt to equity ratio
₹792.29m
Debt
| Interest coverage ratio | 20x |
| Cash | ₹27.90m |
| Equity | ₹3.86b |
| Total liabilities | ₹1.48b |
| Total assets | ₹5.34b |
Recent financial health updates
Chemfab Alkalis (NSE:CHEMFAB) Takes On Some Risk With Its Use Of Debt
Sep 24
Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?
Dec 20Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet
Jan 18We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt
Sep 09
Recent updates
Here's What's Concerning About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Dec 07Earnings Troubles May Signal Larger Issues for Chemfab Alkalis (NSE:CHEMFAB) Shareholders
Nov 12Chemfab Alkalis (NSE:CHEMFAB) Takes On Some Risk With Its Use Of Debt
Sep 24Chemfab Alkalis Limited's (NSE:CHEMFAB) Shares Climb 42% But Its Business Is Yet to Catch Up
Jul 27Be Wary Of Chemfab Alkalis (NSE:CHEMFAB) And Its Returns On Capital
Jul 18Pinning Down Chemfab Alkalis Limited's (NSE:CHEMFAB) P/E Is Difficult Right Now
Jun 12Here's What's Concerning About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Apr 04Market Might Still Lack Some Conviction On Chemfab Alkalis Limited (NSE:CHEMFAB) Even After 30% Share Price Boost
Feb 23Do Chemfab Alkalis' (NSE:CHEMFAB) Earnings Warrant Your Attention?
Jul 18Under The Bonnet, Chemfab Alkalis' (NSE:CHEMFAB) Returns Look Impressive
Feb 11Why We Like The Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 30Be Wary Of Chemfab Alkalis (NSE:CHEMFAB) And Its Returns On Capital
May 10Some Investors May Be Worried About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Feb 02Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?
Dec 20Returns On Capital Are Showing Encouraging Signs At Chemfab Alkalis (NSE:CHEMFAB)
Sep 27Increases to CEO Compensation Might Be Put On Hold For Now at Chemfab Alkalis Limited (NSE:CHEMFAB)
Jul 28Chemfab Alkalis (NSE:CHEMFAB) Is Doing The Right Things To Multiply Its Share Price
Jun 11Could Chemfab Alkalis Limited (NSE:CHEMFAB) Have The Makings Of Another Dividend Aristocrat?
Apr 19Is Chemfab Alkalis (NSE:CHEMFAB) Likely To Turn Things Around?
Feb 25Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet
Jan 18Three Things You Should Check Before Buying Chemfab Alkalis Limited (NSE:CHEMFAB) For Its Dividend
Dec 23What Do The Returns On Capital At Chemfab Alkalis (NSE:CHEMFAB) Tell Us?
Nov 27Are Chemfab Alkalis's (NSE:CHEMFAB) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 01We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt
Sep 09Here’s What’s Happening With Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 03Is Chemfab Alkalis Limited (NSE:CHEMFAB) A Good Fit For Your Dividend Portfolio?
Jul 07Financial Position Analysis
Short Term Liabilities: CHEMFAB's short term assets (₹1.0B) exceed its short term liabilities (₹885.7M).
Long Term Liabilities: CHEMFAB's short term assets (₹1.0B) exceed its long term liabilities (₹594.9M).
Debt to Equity History and Analysis
Debt Level: CHEMFAB's net debt to equity ratio (19.8%) is considered satisfactory.
Reducing Debt: CHEMFAB's debt to equity ratio has increased from 12.7% to 20.5% over the past 5 years.
Debt Coverage: CHEMFAB's debt is not well covered by operating cash flow (15.8%).
Interest Coverage: CHEMFAB's interest payments on its debt are well covered by EBIT (20x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 07:41 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chemfab Alkalis Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |